133 related articles for article (PubMed ID: 38825783)
1. Archaea influence composition of endoscopically visible ileocolonic biofilms.
Orgler E; Baumgartner M; Duller S; Kumptisch C; Hausmann B; Moser D; Khare V; Lang M; Köcher T; Frick A; Muttenthaler M; Makristathis A; Moissl-Eichinger C; Gasche C
Gut Microbes; 2024; 16(1):2359500. PubMed ID: 38825783
[TBL] [Abstract][Full Text] [Related]
2. Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis.
Baumgartner M; Lang M; Holley H; Crepaz D; Hausmann B; Pjevac P; Moser D; Haller F; Hof F; Beer A; Orgler E; Frick A; Khare V; Evstatiev R; Strohmaier S; Primas C; Dolak W; Köcher T; Klavins K; Rath T; Neurath MF; Berry D; Makristathis A; Muttenthaler M; Gasche C
Gastroenterology; 2021 Oct; 161(4):1245-1256.e20. PubMed ID: 34146566
[TBL] [Abstract][Full Text] [Related]
3. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
[TBL] [Abstract][Full Text] [Related]
4. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
[TBL] [Abstract][Full Text] [Related]
5. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y
BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967
[TBL] [Abstract][Full Text] [Related]
6. Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.
Zhong W; Lu X; Shi H; Zhao G; Song Y; Wang Y; Zhang J; Jin Y; Wang S
J Clin Gastroenterol; 2019 Oct; 53(9):660-672. PubMed ID: 29210899
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
[TBL] [Abstract][Full Text] [Related]
8. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome.
Le Gall G; Noor SO; Ridgway K; Scovell L; Jamieson C; Johnson IT; Colquhoun IJ; Kemsley EK; Narbad A
J Proteome Res; 2011 Sep; 10(9):4208-18. PubMed ID: 21761941
[TBL] [Abstract][Full Text] [Related]
10. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels.
Valcheva R; Koleva P; Martínez I; Walter J; Gänzle MG; Dieleman LA
Gut Microbes; 2019; 10(3):334-357. PubMed ID: 30395776
[TBL] [Abstract][Full Text] [Related]
11. An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients.
Scanu M; Toto F; Petito V; Masi L; Fidaleo M; Puca P; Baldelli V; Reddel S; Vernocchi P; Pani G; Putignani L; Scaldaferri F; Del Chierico F
Front Cell Infect Microbiol; 2024; 14():1366192. PubMed ID: 38779566
[TBL] [Abstract][Full Text] [Related]
12. Ileocolonic Histopathological and Microbial Alterations in the Irritable Bowel Syndrome: A Nested Community Case-Control Study.
Talley NJ; Alexander JL; Walker MM; Jones MP; Hugerth LW; Engstrand L; Agréus L; Powell N; Andreasson A
Clin Transl Gastroenterol; 2020 Dec; 12(1):e00296. PubMed ID: 33464728
[TBL] [Abstract][Full Text] [Related]
13. Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome.
Fredericks E; Theunissen R; Roux S
Turk J Gastroenterol; 2020 Dec; 31(12):840-847. PubMed ID: 33625995
[TBL] [Abstract][Full Text] [Related]
14. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW
Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589
[TBL] [Abstract][Full Text] [Related]
15. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
16. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
Katinios G; Casado-Bedmar M; Walter SA; Vicario M; González-Castro AM; Bednarska O; Söderholm JD; Hjortswang H; Keita ÅV
Inflamm Bowel Dis; 2020 Jun; 26(7):974-984. PubMed ID: 31944236
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.
Carroll IM; Ringel-Kulka T; Keku TO; Chang YH; Packey CD; Sartor RB; Ringel Y
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G799-807. PubMed ID: 21737778
[TBL] [Abstract][Full Text] [Related]
18. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
[TBL] [Abstract][Full Text] [Related]
19. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.
Swidsinski A; Weber J; Loening-Baucke V; Hale LP; Lochs H
J Clin Microbiol; 2005 Jul; 43(7):3380-9. PubMed ID: 16000463
[TBL] [Abstract][Full Text] [Related]
20. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
